Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Company News
As of June 4, 2025 • 10:11 AM ET
| Date/Time | Source | News Release |
|---|---|---|
| 12/17/2021 01:00 AM EST | Business Wire | Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership |
| 12/23/2020 02:00 PM EST | Business Wire | The Law Offices of Frank R. Cruz Announces Investigation of Genfit S.A. (GNFT) on Behalf of Investors |
| 03/27/2019 06:13 PM EDT | GlobeNewswire | Nasdaq Welcomes GENFIT S.A. (Nasdaq: GNFT) to The Nasdaq Stock Market |
Page
- 1
Additional News
As of June 4, 2025 • 10:11 AM ET
| Date/Time | Source | News Release |
|---|---|---|
| 05/26/2025 10:32 AM EDT | SeekingAlpha | Gilead Sciences' Best Days May Be Ahead - Here's Why |
| 05/12/2025 01:19 PM EDT | SeekingAlpha | Genfit: Iqirvo's Success Can't Outweigh ACLF Pipeline Risks |
| 04/03/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Thursday, April 3rd, 2025 |
| 04/03/2025 05:30 AM EDT | US Earnings Reports | Expected earnings - GENFIT S.A. |
| 04/02/2025 06:44 PM EDT | KlickAnalytics | GNFT - Historical Earnings Price Analysis |
| 02/21/2025 03:53 AM EST | SeekingAlpha | Genfit reports preliminary results of repurchase offer to 2025 OCEANEs holders |
| 11/21/2024 12:50 AM EST | SeekingAlpha | Genfit Balances Ipsen Partnership With High-Risk Pipeline Ambitions |
| 11/08/2024 10:26 PM EST | Stock Traders Daily | Long Term Trading Analysis for (GNFT) |
| 11/07/2024 06:09 PM EST | SeekingAlpha | Genfit reports 9M results |
| 10/01/2024 05:40 AM EDT | US Earnings Reports | Expected earnings - GENFIT S.A. |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.